Clinical Trials Insight: 700045757
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2010
At a glance
- Drugs Atorvastatin; NCX 6560
- Indications Cardiovascular disorders; Hypercholesterolaemia
- Focus Adverse reactions
- 22 Nov 2010 Status changed from recruiting to completed.
- 18 Nov 2010 Results published in Circulation.
- 18 Nov 2010 Results were presented at the 83rd Scientific Sessions of the American Heart Association (AHA-2010)